Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment.

Héraud C, Bresch S, Bourg V, Landes-Château C, Ruetsch-Chelli C, Ticchioni M, Seitz-Polski B, Lebrun-Frenay C

DOI: 10.1007/s00415-025-13161-6
Published: 2025 Jun 9
Container: Journal of neurology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00415-025-13161-6,
  title = {Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment.},
  author = {Héraud C and Bresch S and Bourg V and Landes-Château C and Ruetsch-Chelli C and Ticchioni M and Seitz-Polski B and Lebrun-Frenay C},
  year = {2025},
  journal = {Journal of neurology},
  doi = {10.1007/s00415-025-13161-6},
  url = {https://doi.org/10.1007/s00415-025-13161-6}
}

RIS

TY  - JOUR
TI  - Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment.
AU  - Héraud C
AU  - Bresch S
AU  - Bourg V
AU  - Landes-Château C
AU  - Ruetsch-Chelli C
AU  - Ticchioni M
AU  - Seitz-Polski B
AU  - Lebrun-Frenay C
PY  - 2025
JO  - Journal of neurology
DO  - 10.1007/s00415-025-13161-6
UR  - https://doi.org/10.1007/s00415-025-13161-6
ER  -

APA

C, H., S, B., V, B., C, L., C, R., M, T., B, S., & C, L. (2025). Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment.. Journal of neurology. https://doi.org/10.1007/s00415-025-13161-6

Source records

pubmed · retrieved 2026-09-26T17:35:49.158Z